Flisser A, Pérez-Montfort R, Larralde C
Bull World Health Organ. 1979;57(5):839-56.
In this review of the literature concerning the immunology of animal and human cysticercosis, emphasis is placed on whether previous exposure to the antigen confers protection to the host. Statistical analysis of the published data indicates that immunized animals have a lower risk than non-immunized animals of contracting cysticercosis, there being large variations within and between different host-cysticercus relationships. There is no indication as to which antigen is best for immunization but, although live parasites in all stages of development, or extracts, appear to give protection, embryos, eggs, and excretions are most frequently used. Antibodies appear to be the principal mediators of resistance, but the action seems to be only upon very young larvae, while fully grown cysticerci are unharmed. Several immunological methods are valuable in the diagnosis of cysticercosis, the choice depending more on the purpose of the study than on differences in their ability to discriminate between healthy and sick. The presence of anticysticercus antibodies in the serum of up to 50% of human patients indicates that human vaccination may be possible in high-risk areas; the remaining patients pose an interesting problem open to speculation and research on immunological evasion, immunodepression, and the existence of serotypes.
在这篇关于动物和人类囊尾蚴病免疫学的文献综述中,重点在于先前接触抗原是否能为宿主提供保护。对已发表数据的统计分析表明,免疫动物感染囊尾蚴病的风险低于未免疫动物,不同宿主 - 囊尾蚴关系之间及内部存在很大差异。目前尚无迹象表明哪种抗原最适合用于免疫,但尽管处于所有发育阶段的活寄生虫或其提取物似乎都能提供保护,但最常使用的是胚胎、虫卵和排泄物。抗体似乎是抗性的主要介导物,但其作用似乎仅针对非常幼小的幼虫,而完全成熟的囊尾蚴则不受影响。几种免疫学方法在囊尾蚴病的诊断中很有价值,选择更多地取决于研究目的,而非它们区分健康与患病的能力差异。高达50%的人类患者血清中存在抗囊尾蚴抗体,这表明在高危地区进行人类疫苗接种可能是可行的;其余患者则带来了一个有趣的问题,有待于对免疫逃避、免疫抑制和血清型的存在进行推测和研究。